Skip to main content
SpringerLink
Log in

Differentiated Thyroid Cancer: Prognostic and Risk Assessment Systems

  • Chapter
  • First Online:
Management of Differentiated Thyroid Cancer

  • 782 Accesses

Abstract

Numerous staging systems have been developed to predict the prognosis of thyroid cancer. Historically these have focused primarily on mortality as the predicted outcome. The key prognostic variables include patient age, tumor size, presence of lymph node or distant metastases, invasive behavior of the tumor, and grade or histology of the tumor. In this chapter, each of these variables is discussed in depth. In addition all of the major staging systems are reviewed including MACIS, TNM, and many others.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71(9):731–4.

    PubMed  Google Scholar 

  2. Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg. 1961;102:354–87.

    Article  CAS  PubMed  Google Scholar 

  3. Halnan KE. Influence of age and sex on incidence and prognosis of thyroid cancer. Three hundred forty-four cases followed for ten years. Cancer. 1966;19(11):1534–6.

    Article  CAS  PubMed  Google Scholar 

  4. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15(8):1033–41.

    Article  CAS  PubMed  Google Scholar 

  5. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102(6):1088–95.

    CAS  PubMed  Google Scholar 

  6. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947–53.

    CAS  PubMed  Google Scholar 

  7. American Cancer Society [Internet]. Atlanta: American Cancer Society, Inc; 2016. [Updated 2015 March 17; cited 2016 March 20]. http://www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-staging

  8. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050–7; discussion 1057–8.

    Google Scholar 

  9. Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell MJ, Shen WT, Vaisman F, Momesso D, Corbo R, Vaisman M, Shaha A, Tuttle RM, Shah JP, Patel SG. Survival from differentiated thyroid cancer: what has age got to do with it? Thyroid. 2015;25(10):1106–14.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Oyer SL, Smith VA, Lentsch EJ. Reevaluating the prognostic significance of age in differentiated thyroid cancer. Otolaryngol Head Neck Surg. 2012;147(2):221–6.

    Article  PubMed  Google Scholar 

  11. Bischoff LA, Curry J, Ahmed I, Pribitkin E, Miller JL. Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer? Endocr Pract. 2013;19(6):995–7.

    Article  PubMed  Google Scholar 

  12. Mazurat A, Torroni A, Hendrickson-Rebizant J, Benning H, Nason RW, Pathak KA. The age factor in survival of a population cohort of well-differentiated thyroid cancer. Endocr Connect. 2013;2(3):154–60.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. Defining a valid age cutoff in staging of well-differentiated thyroid cancer. Ann Surg Oncol. 2016;23(2):410–5.

    Article  PubMed  Google Scholar 

  14. Kim SJ, Myong JP, Suh H, Lee KE, Youn YK. Optimal cutoff age for predicting mortality associated with differentiated thyroid cancer. PLoS One. 2015;10(6):e0130848.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI; National Thyroid Cancer Treatment Cooperative Study Group. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab. 2012;97(6):E878–87.

    Google Scholar 

  16. Wang LY, Ganly I. Nodal metastases in thyroid cancer: prognostic implications and management. Future Oncol. 2016;12(7):981–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. 2008;144(6):1070–7.

    Article  PubMed  Google Scholar 

  18. Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM; American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22(11):1144–52.

    Google Scholar 

  19. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90(10):5723–9.

    Article  CAS  PubMed  Google Scholar 

  20. Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg. 2006;30(10):1821–8.

    Article  PubMed  Google Scholar 

  21. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today. 2006;36(1):12–8.

    Article  PubMed  Google Scholar 

  22. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135(2):139–48.

    Article  PubMed  Google Scholar 

  23. Ito Y, Fukushima M, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J. 2009;56(6):759–66.

    Article  PubMed  Google Scholar 

  24. Wang LY, Palmer FL, Nixon IJ, Thomas D, Shah JP, Patel SG, Tuttle RM, Shaha AR, Ganly I. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer. Thyroid. 2014;24(12):1790–5.

    Article  PubMed  Google Scholar 

  25. Wang LY, Palmer FL, Nixon IJ, Tuttle RM, Shah JP, Patel SG, Shaha AR, Ganly I. Lateral neck lymph node characteristics prognostic of outcome in patients with clinically evident N1b papillary thyroid cancer. Ann Surg Oncol. 2015;22(11):3530–6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237(3):399–407.

    PubMed  PubMed Central  Google Scholar 

  27. Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP, Wan KY. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid. 2013;23(9):1087–99.

    Article  PubMed  Google Scholar 

  28. Yildirim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg. 2005;200(3):378–92.

    Article  PubMed  Google Scholar 

  29. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418–28.

    Article  CAS  PubMed  Google Scholar 

  30. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery. 1994;116(6):1036–40; discussion 1040–1.

    Google Scholar 

  31. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon III HR. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer. 1998;83(5):1012–21.

    Article  CAS  PubMed  Google Scholar 

  32. Sebastian SO, Gonzalez JM, Paricio PP, Perez JS, Flores DP, Madrona AP, Romero PR, Tebar FJ. Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg. 2000;135(3):272–7.

    Article  CAS  PubMed  Google Scholar 

  33. Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol. 1997;15(5):2067–75.

    Article  CAS  PubMed  Google Scholar 

  34. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71(2):414–24.

    Article  CAS  PubMed  Google Scholar 

  35. Wong RM, Bresee C, Braunstein GD. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma. Thyroid. 2013;23(5):566–74.

    Article  PubMed  Google Scholar 

  36. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer. 1993;72(9):2680–5.

    Article  CAS  PubMed  Google Scholar 

  37. Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg. 1994;18(4):552–7.

    Article  CAS  PubMed  Google Scholar 

  38. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for papillary thyroid carcinoma: a review and comparison. Ann Surg. 2007;245(3):366–78.

    Article  PubMed  PubMed Central  Google Scholar 

  39. D’Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE, Clark OH. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid. 2004;14(6):453–8.

    Article  PubMed  Google Scholar 

  40. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Beenken S, Roye D, Weiss H, Sellers M, Urist M, Diethelm A, Goepfert H. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg. 2000;179(1):51–6.

    Article  CAS  PubMed  Google Scholar 

  42. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of North Carolina, Chapel Hill, NC, USA

    Jonathan Black

  2. Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA

    Lawrence Kim

Authors
  1. Jonathan Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lawrence Kim .

Editor information

Editors and Affiliations

  1. General Surgery, Central Arkansas Veterans Healthcare System, University of Arkansas, Little Rock, Arkansas, USA

    Anne T. Mancino

  2. Division of Surgical Oncology, University of North Carolina, Chapel Hill, North Carolina, USA

    Lawrence T. Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2017 The Author(s)

About this chapter

Cite this chapter

Black, J., Kim, L. (2017). Differentiated Thyroid Cancer: Prognostic and Risk Assessment Systems. In: Mancino, A., Kim, L. (eds) Management of Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-54493-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54493-9_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54492-2

  • Online ISBN: 978-3-319-54493-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation